Related Experiment Videos
Glycogen storage disease type III. A case report.
Summary
This study identifies a rare glycogen storage disease in a young boy, characterized by liver and muscle issues. The findings pinpoint deficiencies in specific enzymes, leading to glycogen buildup and related health problems.
Area of Science:
- Biochemistry
- Pediatric Medicine
- Metabolic Disorders
Background:
- Glycogen storage diseases (GSDs) are a group of inherited metabolic disorders affecting glycogen metabolism.
- Understanding the specific enzyme deficiencies is crucial for diagnosis and management of GSDs.
Observation:
- A 5-year-old boy presented with significant hepatomegaly (enlarged liver) and muscle weakness.
- Liver biopsy showed abnormal glycogen accumulation within hepatocytes.
- Elevated erythrocyte glycogen levels, specifically limit dextrin, were detected.
Findings:
- Functional tests indicated reduced activity of amylo-1,6-glucosidase and glucose-6-phosphatase.
- Direct enzyme assays confirmed deficiencies in both amylo-1,6-glucosidase and glucose-6-phosphatase in liver and erythrocytes.
- Decreased glucose-6-phosphatase activity was likely a secondary consequence of limit dextrin accumulation.
Implications:
- This case highlights a complex glycogen storage disease with dual enzyme deficiencies.
- Accurate diagnosis through enzyme assays is vital for appropriate patient care and genetic counseling.
- Further research into the interplay between limit dextrin and glucose-6-phosphatase activity may elucidate disease mechanisms.